Qiu, Xiang et al. published their research in Journal of Hazardous Materials in 2021 |CAS: 5036-48-6

The Article related to laccase abts immobilization magnetic chitosan nanoparticle pollutant removal, abts, ionic liquid, laccase, magnetic chitosan nanoparticles, pollutants removal, Placeholder for records without volume info and other aspects.Name: N-(3-Aminopropyl)-imidazole

On January 5, 2021, Qiu, Xiang; Wang, Shushu; Miao, Shanshan; Suo, Hongbo; Xu, Huajin; Hu, Yi published an article.Name: N-(3-Aminopropyl)-imidazole The title of the article was Co-immobilization of laccase and ABTS onto amino-functionalized ionic liquid-modified magnetic chitosan nanoparticles for pollutants removal. And the article contained the following:

This work aims to achieve the co-immobilization of laccase and 2,2-binamine-di-3-ethylbenzothiazolin-6-sulfonic acid (ABTS) to improve removal capability of the biocatalyst for pollutants while avoiding potential pollution caused by ABTS. The laccase was immobilized on magnetic chitosan nanoparticles modified with amino-functionalized ionic liquid containing ABTS (MACS-NIL) based on Cu ion chelation (MACS-NIL-Cu-lac). The carrier was characterized by Fourier transform IR spectroscopy, thermogravimetric anal., x-ray diffraction and etc., and ESR confirmed the mediator mol. ABTS on the carrier could also play the role of electron transmission. MACS-NIL-Cu-lac presented relatively high immobilization capacity, enhanced activity (1.7-fold that of free laccase), improved pH and temperature adaptability, and increased thermal and storage stability. The removal performance assay found that MACS-NIL-Cu-lac had a good removal efficiency with 100.0 % for 2,4-dichlorophenol in water at 25 掳C, even when the concentration reached 50 mg/L. Reusability study showed that after six catalytic runs, the removal efficiency of 2,4-dichlorophenol by MACS-NIL-Cu-lac could still reach 93.2 %. Addnl., MACS-NIL-Cu-lac exhibited higher catalytic efficiencies with 100.0 %, 70.5 % and 93.3 % for bisphenol A, indole, and anthracene, resp. The high catalytic performance in pure water system obtained by the novel biocatalyst co-immobilizing laccase and electron mediator ABTS showed greater practical application value. The experimental process involved the reaction of N-(3-Aminopropyl)-imidazole(cas: 5036-48-6).Name: N-(3-Aminopropyl)-imidazole

The Article related to laccase abts immobilization magnetic chitosan nanoparticle pollutant removal, abts, ionic liquid, laccase, magnetic chitosan nanoparticles, pollutants removal, Placeholder for records without volume info and other aspects.Name: N-(3-Aminopropyl)-imidazole

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Venkata Mallavadhani, Uppuluri et al. published their research in Journal of Asian Natural Products Research in 2020 |CAS: 5036-48-6

The Article related to cervical lung breast pancreatic cancer antiproliferative usnic acid, (+)- usnic acid, antiproliferative activity, apoptosis, cell cycle arrest, enamine, pyrazole, Placeholder for records without volume info and other aspects.Name: N-(3-Aminopropyl)-imidazole

Venkata Mallavadhani, Uppuluri; Vanga, Nagi Reddy; Balabhaskara Rao, Kancharana; Jain, Nishanth published an article in 2020, the title of the article was Synthesis and antiproliferative activity of novel (+)- usnic acid analogues.Name: N-(3-Aminopropyl)-imidazole And the article contains the following content:

Twenty one novel (+)- usnic acid-based analogs belonging to three classes such as enamines, imines, and pyrazoles were synthesized. All the synthesized compounds were characterized by their spectral data (1H NMR, 13C NMR, IR, and HRMS). The synthesized compounds were evaluated for their antiproliferative activity against a panel of four human cancer cell lines including HeLa (cervix), MDA-MB-231 (breast), A549 (lung), and MiaPaca (pancreas) by employing SRB cell proliferation assay. Screening results indicated that all synthesized compounds showed enhanced activity than the parent compound Most significantly, compounds and showed potent antiproliferative activity against all the cancer cell lines tested. Compounds and arrested the cell cycle in G2/M phase and induced apoptosis in HeLa cells. In view of significant antiproevaliferative activity, compounds and can be considered as lead mols. for further development. The experimental process involved the reaction of N-(3-Aminopropyl)-imidazole(cas: 5036-48-6).Name: N-(3-Aminopropyl)-imidazole

The Article related to cervical lung breast pancreatic cancer antiproliferative usnic acid, (+)- usnic acid, antiproliferative activity, apoptosis, cell cycle arrest, enamine, pyrazole, Placeholder for records without volume info and other aspects.Name: N-(3-Aminopropyl)-imidazole

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Liu, Zhen-zhen et al. published their research in Acta Pharmacologica Sinica in 2021 |CAS: 73590-85-9

The Article related to pimavanserin tartrate calcium calcineurin nfat inhibitor glioblastoma therapy, nfat signaling pathway, soce, drug repurposing, glioblastoma, pimavanserin tartrate, Placeholder for records without volume info and other aspects.Recommanded Product: 73590-85-9

On November 30, 2021, Liu, Zhen-zhen; Liu, Xiao-ning; Fan, Rui-cheng; Jia, Yu-ping; Zhang, Qing-ke; Gao, Xin-qing; Wang, Yu-qing; Yang, Meng-qing; Ji, Li-zhen; Zhou, Yong-qing; Li, Hong-li; Li, Ping; Tang, Bo published an article.Recommanded Product: 73590-85-9 The title of the article was Identification of pimavanserin tartrate as a potent Ca2+-calcineurin-NFAT pathway inhibitor for glioblastoma therapy. And the article contained the following:

Glioblastoma multiforme (GBM) is the most common and malignant type of primary brain tumor, and 95% of patients die within 2 years after diagnosis. In this study, aiming to overcome chemoresistance to the first-line drug temozolomide (TMZ), we carried out research to discover a novel alternative drug targeting the oncogenic NFAT signaling pathway for GBM therapy. To accelerate the drug鈥瞫 clin. application, we took advantage of a drug repurposing strategy to identify novel NFAT signaling pathway inhibitors. After screening a set of 93 FDA-approved drugs with simple structures, we identified pimavanserin tartrate (PIM), an effective 5-HT2A receptor inverse agonist used for the treatment of Parkinson鈥瞫 disease-associated psychiatric symptoms, as having the most potent inhibitory activity against the NFAT signaling pathway. Further study revealed that PIM suppressed STIM1 puncta formation to inhibit store-operated calcium entry (SOCE) and subsequent NFAT activity. In cellula, PIM significantly suppressed the proliferation, migration, division, and motility of U87 glioblastoma cells, induced G1/S phase arrest and promoted apoptosis. In vivo, the growth of s.c. and orthotopic glioblastoma xenografts was markedly suppressed by PIM. Unbiased omics studies revealed the novel mol. mechanism of PIM鈥瞫 antitumor activity, which included suppression of the ATR/CDK2/E2F axis, MYC, and AuroraA/B signaling. Interestingly, the genes upregulated by PIM were largely associated with cholesterol homeostasis, which may contribute to PIM鈥瞫 side effects and should be given more attention. Our study identified store-operated calcium channels as novel targets of PIM and was the first to systematically highlight the therapeutic potential of pimavanserin tartrate for glioblastoma. The experimental process involved the reaction of 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole(cas: 73590-85-9).Recommanded Product: 73590-85-9

The Article related to pimavanserin tartrate calcium calcineurin nfat inhibitor glioblastoma therapy, nfat signaling pathway, soce, drug repurposing, glioblastoma, pimavanserin tartrate, Placeholder for records without volume info and other aspects.Recommanded Product: 73590-85-9

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Feng, Jingxian et al. published their research in Biomaterials in 2020 |CAS: 5036-48-6

The Article related to mangostin triptolide pancreatic cancer drug nanoformulation, acid-triggered micelles, pancreatic cancer, tgf-å°? traditional chinese medicine, triptolide, ä¼?mangostin, Placeholder for records without volume info and other aspects.Product Details of 5036-48-6

On May 31, 2020, Feng, Jingxian; Xu, Minjun; Wang, Jiahao; Zhou, Songlei; Liu, Yipu; Liu, Shanshan; Huang, Yukun; Chen, Yu; Chen, Liang; Song, Qingxiang; Gong, Jingru; Lu, Huiping; Gao, Xiaoling; Chen, Jun published an article.Product Details of 5036-48-6 The title of the article was Sequential delivery of nanoformulated ä¼?mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer. And the article contained the following:

Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease exhibiting the poorest prognosis among solid tumors. The efficacy of conventional therapies has been hindered largely due to the insufficient chemotherapeutic delivery to the dense desmoplastic tumor stroma, and the extremely high or toxic dose needed for chemotherapy. Traditional Chinese Medicine (TCM) contains effective components that can effectively regulate tumor microenvironment and kill tumor cells, providing promising alternatives to PDAC chemotherapy. In this study, two active drug monomers of TCM were screened out and a sequentially targeting delivery regimen was developed to realize the optimized combinational therapy. Transforming growth factor-å°?(TGF-å°? plays an indispensable role in promoting cancer-associated fibroblasts (CAFs) activation and proliferation, and CAFs have caused major phys. barriers for chemotherapeutic drug delivery. Herein, CAFs-targeting biodegradable polymer nanoparticle (CRE-NP(ä¼?M)) coated with CREKA peptide and loaded with TCM ä¼?mangostin (ä¼?M) was developed to modulate tumor microenvironment by interfering of TGF-å°?Smad signaling pathway. Low pH-triggered micelle modified with CRPPR peptide and loaded with another TCM triptolide was constructed to increase the therapeutic effect of triptolide at the tumor sites and reduced its damage to main organs. As expected, CRE-NP(ä¼?M) effectively inactived CAFs, reduced extracellular matrix production, promoted tumor vascular normalization and enhanced blood perfusion at the tumor site. The sequentially targeting drug delivery regimen, CRP-MC(Trip) following CRE-NP(ä¼?M) pretreatment, exhibited strong tumor growth inhibition effect in the orthotopic tumor model. Hence, sequentially targeting delivery of nanoformulated TCM offers an efficient approach to overcome the permeation obstacles and improve the effect of chemotherapy on PDAC, and provides a novel option to treat desmoplastic tumors. The experimental process involved the reaction of N-(3-Aminopropyl)-imidazole(cas: 5036-48-6).Product Details of 5036-48-6

The Article related to mangostin triptolide pancreatic cancer drug nanoformulation, acid-triggered micelles, pancreatic cancer, tgf-å°? traditional chinese medicine, triptolide, ä¼?mangostin, Placeholder for records without volume info and other aspects.Product Details of 5036-48-6

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Tudek, Barbara et al. published their research in American Journal of Translational Research in 2010 |CAS: 55662-66-3

The Article related to review oxidative stress dna damage repair cancer aging, Mammalian Pathological Biochemistry: Reviews and other aspects.Category: imidazoles-derivatives

Tudek, Barbara; Winczura, Alicja; Janik, Justyna; Siomek, Agnieszka; Foksinski, Marek; Olinski, Ryszard published an article in 2010, the title of the article was Involvement of oxidatively damaged DNA and repair in cancer development and aging.Category: imidazoles-derivatives And the article contains the following content:

A review. DNA damage and DNA repair may mediate several cellular processes, like replication and transcription, mutagenesis and apoptosis and thus may be important factors in the development and pathol. of an organism, including cancer. DNA is constantly damaged by reactive oxygen species (ROS) and reactive nitrogen species (RNS) directly and also by products of lipid peroxidation (LPO), which form exocyclic adducts to DNA bases. A wide variety of oxidatively-generated DNA lesions are present in living cells. 8-Oxoguanine (8-oxoGua) is one of the best known DNA lesions due to its mutagenic properties. Among LPO-derived DNA base modifications the most intensively studied are ethenoadenine and ethenocytosine, highly miscoding DNA lesions considered as markers of oxidative stress and promutagenic DNA damage. Although at present it is impossible to directly answer the question concerning involvement of oxidatively damaged DNA in cancer etiol., it is likely that oxidatively modified DNA bases may serve as a source of mutations that initiate carcinogenesis and are involved in aging (i.e. they may be causal factors responsible for these processes). To counteract the deleterious effect of oxidatively damaged DNA, all organisms have developed several DNA repair mechanisms. The efficiency of oxidatively damaged DNA repair was frequently found to be decreased in cancer patients. The present work reviews the basis for the biol. significance of DNA damage, particularly effects of 8-oxoGua and ethenoadduct occurrence in DNA in the aspect of cancer development, drawing attention to the multiplicity of proteins with repair activities. The experimental process involved the reaction of Imidazo[1,2-c]pyrimidin-5(6H)-one(cas: 55662-66-3).Category: imidazoles-derivatives

The Article related to review oxidative stress dna damage repair cancer aging, Mammalian Pathological Biochemistry: Reviews and other aspects.Category: imidazoles-derivatives

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Tudek, Barbara et al. published their research in Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis in 2012 |CAS: 55662-66-3

The Article related to review colon rectum cancer oxidative stress dna repair, Mammalian Pathological Biochemistry: Reviews and other aspects.Formula: C6H5N3O

On August 1, 2012, Tudek, Barbara; Speina, Elzbieta published an article.Formula: C6H5N3O The title of the article was Oxidatively damaged DNA and its repair in colon carcinogenesis. And the article contained the following:

A review. Inflammation, high fat, high red meat and low fiber consumption have for long been known as the most important etiol. factors of sporadic colorectal cancers (CRC). Colon cancer originates from neoplastic transformation in a single layer of epithelial cells occupying colonic crypts, in which migration and apoptosis program becomes disrupted. This results in the formation of polyps and metastatic cancers. Mutational program in sporadic cancers involves APC gene, in which mutations occur most abundantly in the early phase of the process. This is followed by mutations in RAS, TP53, and other genes. Progression of carcinogenic process in the colon is accompanied by augmentation of the oxidative stress, which manifests in the increased level of oxidatively damaged DNA both in the colon epithelium, and in blood leukocytes and urine, already at the earliest stages of disease development. Defense mechanisms are deregulated in CRC patients: (i) antioxidative vitamins level in blood plasma declines with the development of disease; (ii) mRNA level of base excision repair enzymes in blood leukocytes of CRC patients is significantly increased; however, excision rate is regulated sep., being increased for 8-oxoGua, while decreased for lipid peroxidation derived ethenoadducts, 蔚Ade and 蔚Cyt; (iii) excision rate of 蔚Ade and 蔚Cyt in colon tumors is significantly increased in comparison to asymptomatic colon margin, and ethenoadducts level is decreased. This review highlights mechanisms underlying such deregulation, which is the driving force to colon carcinogenesis. The experimental process involved the reaction of Imidazo[1,2-c]pyrimidin-5(6H)-one(cas: 55662-66-3).Formula: C6H5N3O

The Article related to review colon rectum cancer oxidative stress dna repair, Mammalian Pathological Biochemistry: Reviews and other aspects.Formula: C6H5N3O

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Tanaka, Yuta et al. published their patent in 2021 |CAS: 50743-01-6

The Article related to glucosylceramide synthase heterocyclic compound gaucher disease, Pharmaceuticals: Formulation and Compounding and other aspects.Related Products of 50743-01-6

On February 4, 2021, Tanaka, Yuta; Tanaka, Yuta; Kikuchi, Fumiaki; Yamamoto, Takeshi; Nakamura, Minoru; Takami, Kazuaki; Murakami, Masataka; Daini, Masaki; Wada, Yasufumi; Kakegawa, Keiko; Kasahara, Takahito; Ohashi, Tomohiro; Wang, Junsi; Ikeda, Zenichi; Puenner, Florian; Seto, Masaki; Mikami, Satoshi; Sasaki, Minoru published a patent.Related Products of 50743-01-6 The title of the patent was Heterocyclic compound for Gaucher disease. And the patent contained the following:

Provided is a compound which has a glucosylceramide synthase-inhibiting activity and is expected to be useful as a prophylactic or therapeutic agent for a lysosomal storage disease (e.g., Gaucher disease, Fabry disease, GM1-gangliosidosis, GM2 activation factor deficiency disease, Tay-Sachs disease, Sandhoff disease), a neurodegenerative disease (e.g., Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy) and the like. The present invention relates to a compound represented by formula (I); or a salt thereof. The experimental process involved the reaction of 5-Bromo-1H-imidazole-4-carbaldehyde(cas: 50743-01-6).Related Products of 50743-01-6

The Article related to glucosylceramide synthase heterocyclic compound gaucher disease, Pharmaceuticals: Formulation and Compounding and other aspects.Related Products of 50743-01-6

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Pinyakit, Yuwaporn et al. published their research in Journal of Materials Chemistry B: Materials for Biology and Medicine in 2020 |CAS: 5036-48-6

The Article related to pentafluorophenyl ester ph responsive nanocarrier anticancer drug, Pharmaceuticals: Formulation and Compounding and other aspects.Recommanded Product: N-(3-Aminopropyl)-imidazole

Pinyakit, Yuwaporn; Palaga, Tanapat; Kiatkamjornwong, Suda; Hoven, Voravee P. published an article in 2020, the title of the article was Sequential post-polymerization modification of a pentafluorophenyl ester-containing homopolymer: a convenient route to effective pH-responsive nanocarriers for anticancer drugs.Recommanded Product: N-(3-Aminopropyl)-imidazole And the article contains the following content:

Recently, pH-responsive polymeric micelles have gained significant attention as effective carriers for anti-cancer drug delivery. Herein, pH-responsive polymeric micelles were constructed by a simple post-polymerization modification of a single homopolymer, poly(pentafluorophenyl acrylate) (PPFPA). The PPFPA was first subjected to modification with 1-amino-2-propanol yielding the amphiphilic copolymer of poly(pentafluorophenyl acrylate)-ran-poly(N-(2-hydroxypropyl acrylamide)). A series of amphiphilic random copolymers of different compositions could self-assemble into spherical micelles with a unimodal size distribution in aqueous solution Then, 1-(3-aminopropyl)imidazole (API), a reagent to introduce charge conversional entities, was reacted with the remaining PPFPA segment in the micellar core resulting in API-modified micelles which can encapsulate doxorubicin (DOX), a hydrophobic anti-cancer drug. As monitored by dynamic light scattering, the API-modified micelles underwent disintegration upon pH switching from 7.4 to 5.0, presumably due to imidazolyl group protonation. This pH-responsiveness of the API-modified micelles was responsible for the faster and greater in vitro DOX release in an acidic environment than neutral pH. Cellular uptake studies revealed that the developed carriers were internalized into MDA-MB-231 cells within 30 min via endocytosis and exhibited cytotoxicity in a dose-dependent manner. The experimental process involved the reaction of N-(3-Aminopropyl)-imidazole(cas: 5036-48-6).Recommanded Product: N-(3-Aminopropyl)-imidazole

The Article related to pentafluorophenyl ester ph responsive nanocarrier anticancer drug, Pharmaceuticals: Formulation and Compounding and other aspects.Recommanded Product: N-(3-Aminopropyl)-imidazole

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Gu, Zhen et al. published their patent in 2018 |CAS: 5709-67-1

The Article related to patch dual sensitive vesicle insulin delivery polymer preparation, Pharmaceuticals: Formulation and Compounding and other aspects.Name: 2-Nitro-1H-benzo[d]imidazole

On May 11, 2018, Gu, Zhen; Yu, Jicheng published a patent.Name: 2-Nitro-1H-benzo[d]imidazole The title of the patent was Patch loaded with dual-sensitive vesicles for enhanced glucose-responsive insulin delivery. And the patent contained the following:

A composition comprising an amphiphilic polymeric material that is both hydrogen peroxide- and hypoxia-sensitive is described. The composition can further include a glucose-oxidizing enzyme and insulin, a bioactive derivative thereof, and/or another therapeutic agent (e.g., another diabetes treatment agent). The polymeric material can form vesicles that comprise single or multiple layers of the polymeric material that enclose the glucose-oxidizing enzyme and the insulin, bioactive derivative and/or other therapeutic agent. The vesicles can be loaded into microneedles to, for example, prepare microneedle arrays for skin patches. Methods of delivering insulin to a subject using the compositions, vesicles, microneedles, and/or microneedle array skin patches are also described. The experimental process involved the reaction of 2-Nitro-1H-benzo[d]imidazole(cas: 5709-67-1).Name: 2-Nitro-1H-benzo[d]imidazole

The Article related to patch dual sensitive vesicle insulin delivery polymer preparation, Pharmaceuticals: Formulation and Compounding and other aspects.Name: 2-Nitro-1H-benzo[d]imidazole

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Sahnic, Damir et al. published their research in Organic Process Research & Development in 2016 |CAS: 73590-85-9

The Article related to omeprazole synthesis reaction monitoring inline raman spectroscopy, Organic Analytical Chemistry: Determinations and other aspects.Reference of 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole

On December 16, 2016, Sahnic, Damir; Mestrovic, Ernest; Jednacak, Tomislav; Habinovec, Iva; Parlov Vukovic, Jelena; Novak, Predrag published an article.Reference of 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole The title of the article was Monitoring and Quantification of Omeprazole Synthesis Reaction by In-Line Raman Spectroscopy and Characterization of the Reaction Components. And the article contained the following:

The development of a quant. in-line Raman spectroscopic method for the monitoring of the active pharmaceutical ingredient, omeprazole synthesis reaction, and characterization of the reaction components is described. In-line monitoring was performed both with Fourier transform and dispersive Raman spectrometers. Prior to reaction monitoring, the reaction components were characterized off-line by Raman and NMR spectroscopy, both in solution and in solid state. To unequivocally confirm the presence of each component in the reaction mixture, a state of the art LC-SPE/NMR methodol. was also used. Owing to its higher sensitivity, dispersive Raman spectroscopy was further employed for quantification purposes. The spectroscopic measurements and the complementary HPLC analyses, used in the calibration development, were gathered from a set of experiments, performed at a 1 L scale. From the data set obtained from the calibration experiments, a predictive partial least-squares (PLS) regression model was developed for all three reaction components, enabling an accurate determination of the percentage of each component present in the reaction mixture, at any time after the point when 25% of the starting material was consumed. The model was successfully used to monitor the reaction progress in a kilo-lab scale experiment and can further be used as a fast response anal. tool in process optimization. It also has the potential to be used as part of a feedback control loop in the production plant. The experimental process involved the reaction of 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole(cas: 73590-85-9).Reference of 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole

The Article related to omeprazole synthesis reaction monitoring inline raman spectroscopy, Organic Analytical Chemistry: Determinations and other aspects.Reference of 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem